Skip to main content
OpenTrials
Completed

NCT Number: NCT02565225

Mobile Medically Supervised Patient Management in Rheumatoid Arthritis

The purpose of this study is to evaluate the use, usability and feasibility of an Application (App) for patients with rheumatoid arthritis with diary functionalities, in patient-physician interaction.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Rheumatoid Arthritis Arthritis Arthritis, Rheumatoid Autoimmune Diseases Connective Tissue Diseases Immune System Diseases Joint Diseases Musculoskeletal Diseases Rheumatic Diseases Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Policlinic for Rheumatology & Hiller Research Centre for Rheumatology

Düsseldorf, 40225, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age >= 18 years, owner of App capable device, RA, informed consent

Exclusion criteria

  • non German speaking, no App capable device available

Treatment and study plan

RheumaLive App use

Behavioral

Primary outcomes

  1. Evaluation of use of the RheumaLive Application in patients with rheumatoid arthritis.

    Time frame: baseline and change over up to nine months

    Evaluation of use by counting and by a patient paper-based questionnaire

Secondary outcomes

  1. Comparison paper-based vs electronic PROM in the App - Differences of the scores

    Time frame: baseline and change after 3 months

    RADAI - Rheumatoid Arthritis Disease Activity Index and FFbH (Hannover Functional Ability Questionnaire ) / calculated HAQ (Health Assesment Questionnaire)

  2. Evaluation of feasibility of the RheumaLive Application in patients with rheumatoid arthritis.

    Time frame: at 3 months from start and change over 6 more months

    Evaluation of feasibility by a patient and a physician paper-based questionnaire

  3. Evaluation of usability of the RheumaLive Application in patients with rheumatoid arthritis.

    Time frame: at 3 months from start and change over 6 more months

    Evaluation of usability by a patient paper-based questionnaire

Sponsors and collaborators

Lead sponsor

Heinrich-Heine University, Duesseldorf

Other

Registry information

Official study title

Mobile Medically Supervised Patient Management in Rheumatoid Arthritis Patients Using DocuMed.rh and RheumaLive App

Acronym: MiDEAR

Important dates

Study start
2014
Primary completion
2016
Study completion
2016
First posted
Oct 1, 2015
Registry last updated
Sep 26, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.